What parameters of an animal study should you consider at each step — from study design through histopathological analysis?
Dr. Bawa is a leading preclinical research expert with decades of experience in drug and device development. You will learn best practices for setting up a preclinical study that will meet compliance requirements and give you the best chance for regulatory approval.
Who Should Attend:
- Preclinical researchers
- Pharmacology/Toxicology scientists
- Animal study scientists
About Our Speaker:
Rajan Bawa, Ph.D. is the Chief Technology Officer of CARE Research, LLC. Dr. Bawa has been in the pharmaceutical and biotechnology industry for over 40 years. Twenty years ago, he launched a histopathology/hematology/clinpath company, Colorado Histo-Prep. In 2010, the company acquired one of its preclinical CRO clients, which was CARE Research. The resulting enterprise now offers sponsors a single point of control for multiple facets of complex studies for diverse clients in the preclinical space. These range from large pharma, to small biotechs, startups and academic researchers performing translational research.